TABLE 2.
MICs of K. oxytoca isolates obtained during on-site inspection of risk areas
| No. | Species | Sample type | MIC (mg/liter)a |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Piperacillin | Piperacillin-tazobactam | Cefotaxime | Ceftazidime | Imipenem | Meropenem | Amikacin | Ciprofloxacin | |||
| 1 | K. oxytoca | Washing machine | R (>16) | I (16/4) | R (>2) | R (32) | S (≤1) | S (≤0.125) | S (≤4) | R (2) |
| 2 | K. oxytoca | Washing machine | R (>16) | R (>64/4) | R (>2) | R (32) | S (≤1) | S (≤0.125) | S (8) | R (2) |
| 3 | K. oxytoca | Washing machine | R (>16) | R (64/4) | R (>2) | R (32) | S (≤1) | S (≤0.125) | S (8) | R (2) |
| 4 | K. oxytoca | Siphon from wash basin in staff lobby | R (>16) | R (32/4) | R (>2) | R (32) | S (≤1) | S (≤0.125) | S (8) | R (>2) |
| 5 | K. oxytoca | Siphon from wash basin in staff lobby | R (>16) | S (8/4) | R (>2) | R (32) | S (≤1) | S (≤0.125) | S (≤4) | R (2) |
| 6 | K. oxytoca | Siphon from wash basin in staff lobby | R (>16) | I (16/4) | R (>2) | R (64) | S (≤1) | S (≤0.125) | S (≤4) | R (2) |
| 7 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | I (16) | R (>2) |
| 8 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (8) | R (>2) |
| 9 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (8) | R (>2) |
| 10 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (≤4) | R (>2) |
| 11 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (8) | R (>2) |
| 12 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (≤4) | R (>2) |
| 13 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (≤4) | R (2) |
| 14 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (≤4) | R (>2) |
| 15 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (8) | R (>2) |
| 16 | K. oxytoca | Human | R (>16) | R (>64/4) | R (>2) | R (>128) | S (≤1) | S (≤0.125) | S (≤4) | R (>2) |
a
R, resistant; I, intermediate; S, sensitive.